NCT04333225View on ClinicalTrials.gov

Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers

PHASE2CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

April 3, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
COVID-19
Interventions
DRUG

Hydroxychloroquine

Weekly treatment in individuals at high risk

Trial Locations (1)

75226

Baylor University Medical Center, Dallas

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER